Similar to our results, EA was proved to possess a protective effect on concanavalin A-induced hepatitis in mice via decreasing the expressions of TLR2 and TLR4, and suppressing NF-κB signaling pathway [19]. The gene discussed is NFKB1; the disease is hepatitis A virus infection.